Buoyed by enabling legislation and scientific advances, institutions are aggressively shopping their faculties' `blue-sky' investigations. In just the past year, patents on the genes implicated in obesity, breast cancer, and other disorders have generated headlines in newspapers across the United States. In several of these cases, scientists have turned their patented discoveries into lucrative commercial deals worth several times their funding from other sources--crucial money in light of pro
Buoyed by enabling legislation and scientific advances, institutions are aggressively shopping their faculties' `blue-sky' investigations. |
Despite this increased activity, however, scientists insist that the pursuit of a patentable discovery has not become a driving factor in their research strategies. The patent stories in the newspapers are the rare exceptions rather than the rule, they say, and not ...
When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.
View this Issue
In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.
In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.
In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.
Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.
Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST
Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.
Collaboration will bring next generation orchestration and modular automation to scientists worldwide
The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.
